PTGER4 and breast carcinoma: EP4 is widely distributed, has a high affinity for PGE2, activates MAPK and PI3K, drives tumor stem cell features, and induces angiogenesis, lymphangiogenesis, and metastasis in breast cancer and melanoma (26–28).